Skip to main content

Advertisement

ADVERTISEMENT

Volume 20 - Issue 9 - September, 2008

Feature

Case Report
09/15/2008

Neelima Penugonda, MD, Karl Duncan, MD, Theodore Schreiber, MD

Author Affiliations:
From the *Department of Internal Medicine, Wayne State University; the §Department of Cardiology, Wayne State University, and the £Department of Cardiology, Detroit Medical Center, Detroit, Michigan.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted April 11, 2008, provisional acceptance given June 12, 2008, and accepted June 30, 2008.
Address for correspondence: Neelima Penugonda, MD, 5C UHC, 4201 St. Antoin Street, Detroit, MI  48201.  E-mail: pneelu@gmail.com

Neelima Penugonda, MD, Karl Duncan, M...
ABSTRACT: Atherectomy using the FoxHollow device is an exciting treatment as an alternative to lower extremity arterial bypass for treatment of peripheral vascular disease in symptomatic patients with critical limb ischemia and disabling...
ABSTRACT: Atherectomy using the FoxHollow device is an exciting treatment as an alternative to lower extremity arterial bypass for treatment of peripheral vascular disease in symptomatic patients with critical limb ischemia and disabling...
ABSTRACT: Atherectomy using the...
09/15/2008
Journal of Invasive Cardiology
Case Report
09/15/2008

Ali Salami, MD, Shahin Keramati, MD, Ehtisham Mahmud, MD

Author Affiliations:
From the Division of Cardiovascular Medicine, University of California, San Diego School of Medicine, San Diego, California.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted March 10, 2008, provisional acceptance given April 22, 2008, manuscript accepted May 2, 2008.
Address for correspondence: Ehtisham Mahmud, MD, Director, Cardiovascular Catheterization Laboratories, UCSD Medical Center, 200 West Arbor Drive, San Diego, CA  92103-8784.  E-mail: emahmud@ucsd.edu

Ali Salami, MD, Shahin Keramati, MD, ...
ABSTRACT: Acute limb ischemia is a surgical emergency as a delay in reperfusion is associated with a high risk of irreversible tissue infarction potentially leading to limb loss and death. However, in medically compromised patients,...
ABSTRACT: Acute limb ischemia is a surgical emergency as a delay in reperfusion is associated with a high risk of irreversible tissue infarction potentially leading to limb loss and death. However, in medically compromised patients,...
ABSTRACT: Acute limb ischemia is...
09/15/2008
Journal of Invasive Cardiology
Case Report
09/15/2008

Yuri B. Pride, MD, Michael C. Nguyen, MBBS, Lawrence A. Garcia, MD

Author Affiliations:
From the Department of Medicine (YBP) and the Divisions of Interventional Cardiology and Vascular Medicine (MCN, LAG), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted April 18, 2008, provisional acceptance given April 24, 2008, manuscript accepted April 29, 2008.
Address for correspondence: Lawrence A. Garcia, MD, Division of Cardiology, Beth Israel Deaconess Medical Center, 1 Deaconess Road, Boston, Massachusetts  02115.  E-mail: lagarcia@bidmc.harvard.edu

Yuri B. Pride, MD, Michael C. Nguyen,...
ABSTRACT: We describe a case of a 51-year-old female who was incidentally noted to have a renal artery aneurysm on computed tomography (CT). The aneurysm was not seen on an abdominal CT performed 4 years prior, so the patient underwent...
ABSTRACT: We describe a case of a 51-year-old female who was incidentally noted to have a renal artery aneurysm on computed tomography (CT). The aneurysm was not seen on an abdominal CT performed 4 years prior, so the patient underwent...
ABSTRACT: We describe a case of...
09/15/2008
Journal of Invasive Cardiology
Review
09/15/2008

Thomas J. Kiernan, MD, Andrew E. Ajani, MBBS, MD,  Bryan P. Yan, MBBS

Author Affiliations:
From the 1Cardiology Division, Section of Vascular Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, 2Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia, 3University of Melbourne, Melbourne, Victoria, Australia.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted March 18, 2008, provisional acceptance given May 8, 2008, manuscript accepted May 27, 2008.
Address for correspondence: Bryan Yan, MD, Cardiology Division, Massachusetts General Hospital, 55 Fruit Street GRB-800, Boston MA 02114. E-mail: bryan.p.yan@gmail.com

Thomas J. Kiernan, MD, Andrew E. Ajan...
ABSTRACT: The role of endovascular therapy for the treatment of coronary and peripheral vascular diseases (including carotid, renal and lower extremity arteries) is expanding. The steady growth in the volume of endovascular procedures is...
ABSTRACT: The role of endovascular therapy for the treatment of coronary and peripheral vascular diseases (including carotid, renal and lower extremity arteries) is expanding. The steady growth in the volume of endovascular procedures is...
ABSTRACT: The role of...
09/15/2008
Journal of Invasive Cardiology
Original Contribution
09/15/2008

Suwatchai Pornratanarangsi, MD, Seif S. El-Jack, MD, Mark W. I. Webster, MD, Duncan McNab, MD,
James T. Stewart, MD, John A. Ormiston, MD, Peter N. Ruygrok, MD

Author Affiliations:
From the Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.
Disclosures: MWIW is the inventor of the Xtract thrombectomy catheter (Lumen Biomedical); JAO is on the scientific advisory boards of Boston Scientifc Corp. and Abbott Vascular.
Manuscript submitted June 4, 2007, provisional acceptance (version 1) given July 19, 2007, final version accepted June 3, 2008.
Address correspondence to: Mark W. I. Webster, MD, Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92 024, Auckland 1031, New Zealand.  E-mail: mwebster@adhb.govt.nz

Suwatchai Pornratanarangsi, MD, Seif ...
ABSTRACT: Patients with large intracoronary thrombi represent a difficult management problem for the interventional cardiologist. We report 10 cases of challenging thrombi treated percutaneously using varying combinations of deep guide...
ABSTRACT: Patients with large intracoronary thrombi represent a difficult management problem for the interventional cardiologist. We report 10 cases of challenging thrombi treated percutaneously using varying combinations of deep guide...
ABSTRACT: Patients with large...
09/15/2008
Journal of Invasive Cardiology
Original Contribution
09/15/2008

Jonathan D. Marmur, MD, Manish Lakhani, MD, *Soumaya El Rouby, MD, Erdal Cavusoglu, MD

Author Affiliations:
From the SUNY Health Sciences Center at Brooklyn, Brooklyn, New York and *International Technidyne Corporation, Edison, New Jersey.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted February 22, 2008, provisional acceptance given April 16, 2008, manuscript accepted May 19, 2008.
Address correspondence to: Jonathan D. Marmur, MD, FACC, Department of Cardiology, SUNY Health Sciences Center at Brooklyn, 450 Clarkson Avenue, Box 1257, Brooklyn, NY  11203.  E-mail: jonathan@marmur.com

Jonathan D. Marmur, MD, Manish Lakhan...
ABSTRACT: Background. We designed a study to compare the novel point-of-care assay Hemonox clotting time (Hemonox-CT) with the activated clotting time (ACT) and anti-Xa activity to monitor the anticoagulation effects of enoxaparin and...
ABSTRACT: Background. We designed a study to compare the novel point-of-care assay Hemonox clotting time (Hemonox-CT) with the activated clotting time (ACT) and anti-Xa activity to monitor the anticoagulation effects of enoxaparin and...
ABSTRACT: Background. We...
09/15/2008
Journal of Invasive Cardiology
Original Contribution
09/15/2008

Christian Spies, MD, Ulrich Reissmann, MD, Ines Timmermanns, RN, Rainer Schräder, MD

Author Affiliations:
From the *Section of Cardiology, Rush University Medical Center, Chicago, Illinois; §Medizinische Klinik III, Markuskrankenhaus, Frankfurt, Germany; and £Cardioangiologisches Centrum Bethanien (CCB), Frankfurt, Germany.
Disclosures: Dr. Schräder has received speaker honoraria from and serves as a proctor for Cardia, Inc., and has received travel grants from AGA Medical Corp.
Manuscript submitted April 8, 2008 and accepted June 10, 2008.
Address for correspondence: Prof. Dr. med. Rainer Schräder, Markuskrankenhaus, Medizinische Klinik III – CCB, Wilhelm-Epstein-Strasse 2, 60431 Frankfurt, Germany.  E-mail: r.schraeder@ccb.de

Christian Spies, MD, Ulrich Reissmann...
ABSTRACT: Background. Transcatheter patent foramen ovale (PFO) closure can be performed with various devices. However, their handling, safety, presence of residual shunt and impact on recurrent thromboembolic events (TEs) are rarely compared...
ABSTRACT: Background. Transcatheter patent foramen ovale (PFO) closure can be performed with various devices. However, their handling, safety, presence of residual shunt and impact on recurrent thromboembolic events (TEs) are rarely compared...
ABSTRACT: Background....
09/15/2008
Journal of Invasive Cardiology
Original Contribution
09/15/2008

Emily A. Ferenczi, BA, BMBCh, Iqbal S. Malik, MD, MRCP, Jamil Mayet, MD, FRCP,
Rodney A. Foale, FRCP, Darrel P. Francis, MA, MRCP

Author Affiliations:
From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College and St. Mary’s Hospital, United Kingdom.
The authors report no conflicts of interest regarding the content herein. Support from the British Heart Foundation is acknowledged.
Manuscript submitted February 25, 2008, provisional acceptance given April 16, 2008, manuscript accepted June 3. 2008.
Address for correspondence: E. Ferenczi, BA, BMBCh, International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College and St Mary’s Hospital, 59-61 North Wharf Road, London W2 1LA. E-mail: emily.ferenczi@doctors.org.uk

Emily A. Ferenczi, BA, BMBCh, Iqbal S...
References    ABSTRACT: Background. At 30 days, it is recognized that 12-hour periprocedural abciximab infusion protects against reinfarction and the need for revascularization in percutaneous coronary intervention (PCI) in acute myocardial...
References    ABSTRACT: Background. At 30 days, it is recognized that 12-hour periprocedural abciximab infusion protects against reinfarction and the need for revascularization in percutaneous coronary intervention (PCI) in acute myocardial...
References    ABSTRACT:...
09/15/2008
Journal of Invasive Cardiology
Original Contribution
09/15/2008

Young Joon Hong, MD, *Gary S. Mintz, MD, Sang Wook Kim, MD, Teruo Okabe, MD, Anh B. Bui, MD,
Augusto D. Pichard, MD, Lowell F. Satler, MD, Ron Waksman, MD, Neil J. Weissman, MD

Author Affiliations:
From the Cardiovascular Research Institute/Medstar Research Institute, Washington Hospital Center, Washington, D.C., and the *Cardiovascular Research Foundation, New York, New York.
Disclosure: Dr. Mintz has received speaker honoraria and Fellowship support from Boston Scientific Corp.; he also has stock ownership in Volcano Corp., and is a consultant to and research grant recipient from the same.
Manuscript submitted March 7, 2008, provisional acceptance given April 18, 2008, manuscript accepted June 11, 2008.
Address for correspondence: Neil J. Weissman, MD, 100 Irving Street, N.W., Suite EB-5123, Washington, D.C. 20010.  E-mail: Neil.J.Weissman@medstar.net

Young Joon Hong, MD, *Gary S. Mintz, ...
ABSTRACT: Background. Ruptured plaques are associated with elevated C-reactive protein (CRP) that, in turn, are associated with a poor prognosis in acute myocardial infarction (AMI) patients. Objectives. The purpose of this study was to...
ABSTRACT: Background. Ruptured plaques are associated with elevated C-reactive protein (CRP) that, in turn, are associated with a poor prognosis in acute myocardial infarction (AMI) patients. Objectives. The purpose of this study was to...
ABSTRACT: Background. Ruptured...
09/15/2008
Journal of Invasive Cardiology

Insights

Commentary
09/15/2008

Bernhard Meier, MD

Author Affiliations:
From the Cardiovascular Department, University Hospital Bern, Bern, Switzerland.
Disclosures: Dr. Meier has received speaker honoraria, research grants, travel grants and consulting fees from AGA Medical Corporation.
Address for correspondence: Bernhard Meier, MD, Professor and Chairman of Cardiology, Cardiovascular Department, University Hospital Bern, 3010 Bern, Switzerland.  E-mail: bernhard.meier@insel.ch

Bernhard Meier, MDAuthor Affiliations...
The series of percutaneous closure of a patent foramen ovale (PFO) presented by the German institution represents one of the largest experiences worldwide.1 It is only natural that these pioneers of the Cardia device then moved on to its next...
The series of percutaneous closure of a patent foramen ovale (PFO) presented by the German institution represents one of the largest experiences worldwide.1 It is only natural that these pioneers of the Cardia device then moved on to its next...
The series of percutaneous...
09/15/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement